Valuation : Qlucore AB

Market Cap 17.12M 1.79M 1.54M 1.44M 1.32M 2.47M 169M 2.47M 6.61M 86.44M 6.7M 6.56M 278M P/E 2025
-0.35x
P/E 2026 -0.38x
Enterprise Value 15.55M 1.62M 1.39M 1.31M 1.2M 2.24M 153M 2.25M 6.01M 78.52M 6.09M 5.96M 252M EV / Sales 2025
0.21x
EV / Sales 2026 1.77x
Free-Float
23.51%
Yield 2025 *
-
Yield 2026 -
1 day-9.11%
1 week-3.39%
Current month-6.99%
1 month+6.12%
3 months-9.73%
6 months-10.54%
Current year-19.88%
1 week 0.39
Extreme 0.392
0.45
1 month 0.31
Extreme 0.31
0.51
Current year 0.21
Extreme 0.213
0.58
1 year 0.21
Extreme 0.213
1
3 years 0.21
Extreme 0.213
11.5
5 years 0.21
Extreme 0.213
58
10 years 0.21
Extreme 0.213
58
Manager TitleAgeSince
Chief Executive Officer 58 04/12/2006
Director of Finance/CFO - 31/01/2022
Chief Tech/Sci/R&D Officer - 06/02/2022
Director TitleAgeSince
Chairman 72 31/12/2017
Director/Board Member 68 31/12/2006
Director/Board Member 63 04/12/2006
Change 5-day change 1-year change 3-year change Capi.($)
-9.11%-3.39%-47.84%-96.16% 1.97M
-2.04%-2.69%+0.95%+50.11% 3,711B
-4.49%-6.42%+13.86%+1,039.41% 419B
-3.99%-14.01%-16.61%+18.65% 80.61B
-0.85%-10.15%+56.47%+118.03% 76.46B
-5.40%-11.02%-34.16%-15.43% 75.47B
-0.89%-6.09%-41.50%+185.80% 68.65B
-2.62%-0.44%+9.95%-8.15% 47.99B
+0.26%-8.79%-10.43%+52.29% 40.14B
-3.12%-2.02%+114.39%+252.57% 35.78B
Average -3.22%-5.53%+4.51%+159.71% 455.46B
Weighted average by Cap. -2.31%-3.57%+2.42%+143.65%

Financials

2025 2026
Net sales 18.43M 1.92M 1.65M 1.55M 1.42M 2.65M 182M 2.66M 7.12M 93.07M 7.22M 7.06M 299M 10.36M 1.08M 929K 874K 797K 1.49M 102M 1.5M 4M 52.33M 4.06M 3.97M 168M
Net income -20.54M -2.14M -1.84M -1.73M -1.58M -2.96M -202M -2.97M -7.93M -104M -8.04M -7.87M -333M -36.52M -3.81M -3.28M -3.08M -2.81M -5.26M -360M -5.28M -14.11M -184M -14.31M -13.99M -592M
Net Debt -3.26M -340K -292K -275K -251K -469K -32.11M -471K -1.26M -16.45M -1.28M -1.25M -52.82M -1.57M -164K -141K -132K -121K -226K -15.46M -227K -606K -7.92M -615K -601K -25.44M
Logo Qlucore AB
Qlucore AB (publ) is a Sweden-based company primarily engaged in the software industry. The Company’s scope of activity revolves around developing Artificial-Intelligence-based (AI-based) software dedicated to the healthcare sector. The software’s aim is to establish a platform improving cancer care in terms of treatment strategies, and more, as well as other therapy areas. What is more, the Firm develops software which is committed to data analysis in relation to medical research. The Company’s software relies on AI-based machine learning and functions by transforming data sets into explanatory visualizations. Additionally, the Firm runs three software products: Qlucore Omics Explorer, Qlucore Diagnostics, as well as Qlucore Insights.
Employees
15
Date Price Change Volume
07/09/26 SEK 0.3990 -9.11% 28,886
04/09/26 SEK 0.4390 +2.33% 559
  1. Stock Market
  2. Stocks
  3. QCORE Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!